Delivery Order SPE2DB20D2104-SPE2DB25FMAGP
Award Date
10/10/24
Potential Completion Date
11/1/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ingrezza 80 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a fixed-price delivery order type and was awarded without any set-aside designation, indicating open competition. The total ceiling value of the contract is $3,714.98, with an ultimate completion date of November 16, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of Ingrezza 80 mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has a ceiling value of $3,893.15 and is a firm fixed-price delivery order that runs through June 3, 2024. It is not a set-aside contract. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,352.24 delivery order contract is for the supply of Ingrezza 40 mg capsules, a medication used to treat neurological conditions. The contract has a firm fixed price and an ultimate completion date of May 28, 2025. This award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ingrezza 40 mg capsules to the U.S. government. The contract, valued at $10,659.93, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for pharmaceutical products and medical supplies. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical and a $750,000 IDC with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ingrezza 40 mg capsules. The contract has a ceiling value of $9,358.65 and an ultimate completion date of May 6, 2022. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,676.12, is for the delivery of the pharmaceutical product Ingrezza 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 7, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Ingrezza 40 mg capsules. The $3,119.55 firm fixed-price delivery order has an ultimate completion date of April 10, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of Ingrezza 80 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $11,144.94, with a firm fixed price. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.31 firm fixed-price delivery order is for the provision of Ingrezza 40 mg capsules, a medication used to treat a neurological disorder. This award is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4564340682 Ingrezza 40 MG capsules in quantities of 30s. The contract has a ceiling value of $14,213.24 and a performance period ending on May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025....